CC BY 4.0 · Endoscopy 2023; 55(S 01): E1079-E1080
DOI: 10.1055/a-2161-3286
E-Videos

Digital single-operator cholangioscopy-guided endoluminal radiofrequency of an intraductal papillary mucinous neoplasia of the main pancreatic duct

Xin Deng
1   Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
,
Jingwen Wang
2   Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
,
Tong Mou
1   Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
,
Long Pan
1   Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
,
Bin Li
1   Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
,
Chengyou Du
1   Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
,
Qiao Wu
1   Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
› Author Affiliations
 

A 64-year-old woman with a history of recurrent acute pancreatitis was referred for treatment of intraductal papillary mucinous neoplasia (IPMN) that was found during a computed tomography (CT) scan in a local hospital. Magnetic resonance cholangiography (MRCP) presented dilation of the main pancreatic duct and suspicious nodules in the main pancreatic duct ([Fig. 1]). Endoscopic retrograde cholangiopancreatography (ERCP) showed that the pancreatic duct was significantly dilatated and there seemed to be a cystic lesion at the head of the pancreas ([Fig. 2]). Further evaluation of digital single-operator cholangioscopy (DSOC) found that the pancreatic duct was full of thick, mucinous fluid, and a few of papillary neoplasms were located at the junction of the main branch and branches of the pancreatic duct in the head of the pancreas ([Video 1]). Tissues were obtained by biopsy forceps and histopathologically examined.

Zoom Image
Fig. 1 Magnetic resonance cholangiography (MRCP) showed dilation of the main pancreatic duct and suspicious nodules in the main pancreatic duct.
Zoom Image
Fig. 2 Endoscopic retrograde cholangiopancreatography (ERCP) showed dilation of the main pancreatic duct, which was the same as in the MRCP; however, there were no obvious filling defects.

Video 1 Digital single-operator cholangioscopy (DSOC) was used to examine the pancreatic duct. Neoplastic tissues were biopsied and then destroyed by endoluminal radiofrequency under direct vision.


Quality:

The patient and her relatives all refused to have her undergo radical surgery, and intraductal radiofrequency ablation (RFA) was offered. A novel radiofrequency operation electrode was inserted into the pancreatic duct over DSOC ([Fig. 3]). DSOC-guided endoluminal radiofrequency was used to destroy the neoplasms under direct vision. After radiofrequency ablation, these neoplasms became necrotic ([Fig. 4]). A 5-Fr stent was placed to prevent secondary stenosis ([Fig. 5]). No adverse events occurred. Finally, pathology examination revealed IPMN with mild dysplasia. To date, the patient has not developed acute pancreatitis again after 3 months of follow-up.

Zoom Image
Fig. 3 A digital single-operator cholangioscopy (DSOC)-guided endoluminal radiofrequency catheter was inserted into the pancreatic duct. The working channel diameter of this catheter was 1 mm; the working channel length was 5 mm.
Zoom Image
Fig. 4 The papillary neoplasms were found by DSOC. After radiofrequency ablation, these neoplasms became necrotic.
Zoom Image
Fig. 5 A 5-Fr stent was placed to prevent secondary stenosis and post-ERCP pancreatitis.

RFA ablates neoplastic tissue via local thermal coagulative necrosis [1]. Previous studies have shown that endoscopic biliopancreatic RFA is a safe and effective therapy [2] [3] [4]. However, these methods are guided by fluoroscopic images. The present case report is the first to report the use of a DSOC-guided endoluminal radiofrequency catheter. The effective outcome and uneventful recovery suggest that this technique could be offered with a curative intent in selected patients. Meanwhile, it could offer a novel, accurate, and microinvasive treatment method for pancreatic duct-related disorders.

Endoscopy_UCTN_Code_TTT_1AR_2AF

Endoscopy E-Videos
https://eref.thieme.de/e-videos

E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/).

This section has its own submission website at https://mc.manuscriptcentral.com/e-videos


#

Competing interests

The authors declare that they have no conflict of interest.

  • References

  • 1 Rustagi T, Chhoda A. Endoscopic radiofrequency ablation of the pancreas. Dig Dis Sci 2017; 62: 843-850
  • 2 Lorenzo D, Barret M, Bordacahar B. et al. Intraductal radiofrequency ablation of an intraductal papillary mucinous neoplasia of the main pancreatic duct. Endoscopy 2018; 50: 176-177
  • 3 Xia MX, Wang SP, Yuan JG. et al. Effect of endoscopic radiofrequency ablation on the survival of patients with inoperable malignant biliary strictures: A large cohort study. J Hepatobiliary Pancreat Sci 2022; 29: 693-702
  • 4 Zheng X, Bo ZY, Wan W. et al. Endoscopic radiofrequency ablation may be preferable in the management of malignant biliary obstruction: A systematic review and meta-analysis. J Dig Dis 2016; 17: 716-724

Corresponding author

Qiao Wu, MD
Department of Hepatobiliary Surgery
The First Affiliated Hospital of Chongqing Medical University
No. 1 Yixueyuan Road, Yuzhong District
Chongqing 400016
China   

Publication History

Article published online:
27 September 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • References

  • 1 Rustagi T, Chhoda A. Endoscopic radiofrequency ablation of the pancreas. Dig Dis Sci 2017; 62: 843-850
  • 2 Lorenzo D, Barret M, Bordacahar B. et al. Intraductal radiofrequency ablation of an intraductal papillary mucinous neoplasia of the main pancreatic duct. Endoscopy 2018; 50: 176-177
  • 3 Xia MX, Wang SP, Yuan JG. et al. Effect of endoscopic radiofrequency ablation on the survival of patients with inoperable malignant biliary strictures: A large cohort study. J Hepatobiliary Pancreat Sci 2022; 29: 693-702
  • 4 Zheng X, Bo ZY, Wan W. et al. Endoscopic radiofrequency ablation may be preferable in the management of malignant biliary obstruction: A systematic review and meta-analysis. J Dig Dis 2016; 17: 716-724

Zoom Image
Fig. 1 Magnetic resonance cholangiography (MRCP) showed dilation of the main pancreatic duct and suspicious nodules in the main pancreatic duct.
Zoom Image
Fig. 2 Endoscopic retrograde cholangiopancreatography (ERCP) showed dilation of the main pancreatic duct, which was the same as in the MRCP; however, there were no obvious filling defects.
Zoom Image
Fig. 3 A digital single-operator cholangioscopy (DSOC)-guided endoluminal radiofrequency catheter was inserted into the pancreatic duct. The working channel diameter of this catheter was 1 mm; the working channel length was 5 mm.
Zoom Image
Fig. 4 The papillary neoplasms were found by DSOC. After radiofrequency ablation, these neoplasms became necrotic.
Zoom Image
Fig. 5 A 5-Fr stent was placed to prevent secondary stenosis and post-ERCP pancreatitis.